An Efficacy and Safety Study of Alirocumab in Children and Adolescents With Homozygous Familial Hypercholesterolemia An Efficacy and Safety Study of Alirocumab in Children and Adolescents With Homozygous Familial Hype ...
An Open-Label Study to Evaluate the Efficacy and Safety of Alirocumab in Children and Adolescents With Homozygous Familial Hypercholesterolemia An Open-Label Study to Evaluate the Efficacy and Safety of Alirocumab in Children and Adolescents Wi ...
Safety and Tolerability Study of Ezetimibe (SCH 058235/MK-0653) Plus Atorvastatin or Simvastatin in Homozygous Familial Hypercholesterolemia (P01417/MK-0653-019) Safety and Tolerability Study of Ezetimibe (SCH 058235/MK-0653) Plus Atorvastatinor Simvastatin in H ...
Long-Term, Open-Label, Safety and Tolerability Study of SCH 58235 in Addition to Atorvastatin or Simvastatin in the Therapy of Homozygous Familial Hypercholesterolemia Long-Term, Open-Label, Safety and Tolerability Study of SCH 58235 in Addition to Atorvastatinor Simv ...
Ezetimibe (SCH 58235) Taken With Either Atorvastatin or Simvastatin in Participants With Familial Hypercholesterolemia (MK-0653-018) Ezetimibe (SCH 58235) Taken With Either Atorvastatinor Simvastatin in Participants With Familial Hyp ...
A Phase III Efficacy And Safety Study of Ezetimibe (SCH58235) 10 mg in Addition to Atorvastatin or Simvastatin in the Therapy of Homozygous Familial Hypercholesterolemia A Phase III Efficacy And Safety Study of Ezetimibe (SCH58235) 10 mg in Addition to Atorvastatinor Si ...